AF Cardioversion Anticoagulation

For AF documented as lasting 48 hours or longer, use either of two pathways before elective electrical or pharmacologic cardioversion: uninterrupted therapeutic oral anticoagulation for 3 weeks, or imaging to exclude intracardiac thrombus. The thromboembolic precautions apply equally to pharmacologic and electrical cardioversion. PubMedPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

Treat an uncertain onset time as a thrombus-risk scenario rather than relying on symptom onset alone. Contemporary practice commonly uses TEE to exclude left atrial or left atrial appendage thrombus when expedited cardioversion is needed and adequate preceding anticoagulation has not been completed. AHA Journals+2AHA JournalsIdentifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS‐AF ScoreAHA JournalsPreprocedural Multimodality Imaging in Atrial Fibrillation | CirculationPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

Do not use successful restoration of sinus rhythm as a reason to abbreviate anticoagulation. Cardioversion can embolize pre-existing thrombus and is followed by atrial mechanical dysfunction, or atrial stunning, and a transient prothrombotic state. PubMedPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

DOACs are accepted alternatives to vitamin K antagonists for thromboprophylaxis around cardioversion. In patients without a contraindication to DOAC therapy, their rapid onset, reliable maintenance of therapeutic effect, and ease of continuation make them a preferred practical option in the ACC/AHA/ACCP/HRS guideline discussion. PubMedPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

If warfarin is used, ensure therapeutic anticoagulation rather than counting calendar time alone. The cardioversion literature describes warfarin therapy with therapeutic INR 2.0 to 3.0; interruption or subtherapeutic anticoagulation undermines the conventional delayed-cardioversion pathway. PubMed+1PubMedAnticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account - PMCPubMedPharmacological Cardioversion - StatPearls - NCBI Bookshelf

Do not substitute aspirin for therapeutic anticoagulation when cardioversion-related embolic protection is required. Adjusted-dose warfarin is substantially more efficacious than aspirin for stroke prevention in AF, and current cardioversion guidance specifies therapeutic anticoagulation before and after the procedure. acpjournals+1acpjournalsAntithrombotic Therapy To Prevent Stroke in Patients with Atrial ...PubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

TEE-guided cardioversion is the alternative to waiting through the 3-week anticoagulation interval when AF is 48 hours or longer or onset is uncertain. A study of anticoagulated AF/AFL populations found a mean-weighted left atrial thrombus prevalence of 2.73%, emphasizing that anticoagulation exposure lowers but does not abolish thrombus risk. ScienceDirect+1ScienceDirectPrevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial FibrillationPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

Use heightened caution in patients with nonparoxysmal AF/AFL or CHA2DS2-VASc score of 3 or greater. In the cited systematic review, left atrial thrombus prevalence was 4.81% in nonparoxysmal versus lower prevalence in paroxysmal AF/AFL, and 6.31% among those with CHA2DS2-VASc scores of 3 or greater. ScienceDirectScienceDirectPrevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation

If TEE excludes intracardiac thrombus, cardioversion may proceed under therapeutic anticoagulation, but continue anticoagulation for at least 4 weeks afterward. A negative study addresses pre-existing thrombus; it does not prevent embolic risk related to post-cardioversion atrial stunning or early AF recurrence. PubMed+1PubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMCACCCardioversion in Atrial Fibrillation - American College of Cardiology

When pre-cardioversion imaging detects LAA thrombus, do not proceed with cardioversion. Institute therapeutic anticoagulation for at least 3 to 6 weeks and repeat imaging before reconsidering cardioversion. PubMedPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

This repeat-imaging step is clinically consequential because left atrial thrombus can persist despite guideline-directed anticoagulation. Across studies of patients treated continuously for at least 3 weeks, mean-weighted prevalence was 2.73%; prevalence was higher in nonparoxysmal AF/AFL and in patients with CHA2DS2-VASc score 3 or greater. ScienceDirectScienceDirectPrevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation

Reassess the urgency of rhythm restoration while thrombus is treated. If cardioversion is no longer needed because symptoms or ventricular response are acceptable, avoid exposing the patient to a repeat procedure solely to document sinus rhythm; if cardioversion remains planned, use repeat imaging to determine whether the thrombus-related procedural barrier has resolved. PubMedPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

Therapeutic anticoagulation should be established before cardioversion and continued without interruption for at least 4 weeks afterward. This recommendation applies to AF cardioversion regardless of whether the patient reached the procedure through 3 weeks of anticoagulation or through an imaging-guided strategy. PubMedPubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMC

The early post-cardioversion period is a high-risk interval: thromboembolic events are concentrated during the first month and particularly within the first 10 days in reported clinical summaries. The biologic rationale includes atrial stunning after sinus rhythm restoration, possible embolization of previously present thrombus, early AF recurrence, and a transient prothrombotic state. PubMed+1PubMed2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines - PMCACCCardioversion in Atrial Fibrillation - American College of Cardiology

At the end of the mandatory 4-week interval, make the longer-term anticoagulation decision separately from the cardioversion decision, based on the patient's ongoing AF-related thromboembolic risk and clinical context. Do not let apparent maintenance of sinus rhythm alone substitute for longitudinal stroke-prevention assessment. ScienceDirect+1ScienceDirectAnalysis of The 2024 ESC/EACTS Guidelines For The Management ...ESC2024 ESC Guidelines for the management of atrial fibrillation